MEDICLIN Aktiengesellschaft (MED.DE)
EUR 2.42
(0.0%)
EUR 2.42
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 761.59 Million EUR | 3.6% |
| 2022 | 704.7 Million EUR | 4.69% |
| 2021 | 673.1 Million EUR | 2.0% |
| 2020 | 659.9 Million EUR | -1.96% |
| 2019 | 673.1 Million EUR | 4.34% |
| 2018 | 645.1 Million EUR | 5.91% |
| 2017 | 609.1 Million EUR | 4.96% |
| 2016 | 580.34 Million EUR | 4.5% |
| 2015 | 555.34 Million EUR | 3.22% |
| 2014 | 538.03 Million EUR | 4.48% |
| 2013 | 514.95 Million EUR | 1.02% |
| 2012 | 509.73 Million EUR | 3.28% |
| 2011 | 493.56 Million EUR | 1.31% |
| 2010 | 487.16 Million EUR | 3.52% |
| 2009 | 470.57 Million EUR | 3.02% |
| 2008 | 456.79 Million EUR | 0.0% |
| 2007 | - EUR | 0.0% |
| 2006 | - EUR | -100.0% |
| 2005 | 370.43 Million EUR | -0.69% |
| 2004 | 373.02 Million EUR | -0.83% |
| 2003 | 376.13 Million EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 182.53 Million EUR | -1.57% |
| 2024 Q1 | 185.44 Million EUR | 1.37% |
| 2023 Q4 | 182.93 Million EUR | 0.32% |
| 2023 Q2 | 188.08 Million EUR | 6.44% |
| 2023 Q3 | 182.35 Million EUR | -3.05% |
| 2023 Q1 | 176.7 Million EUR | -0.94% |
| 2023 FY | 730.07 Million EUR | 3.6% |
| 2022 Q3 | 170.98 Million EUR | -5.59% |
| 2022 FY | 704.7 Million EUR | 4.69% |
| 2022 Q1 | 174.24 Million EUR | -0.46% |
| 2022 Q4 | 178.37 Million EUR | 4.32% |
| 2022 Q2 | 181.1 Million EUR | 3.94% |
| 2021 Q1 | 156.36 Million EUR | -3.0% |
| 2021 Q2 | 166.75 Million EUR | 6.64% |
| 2021 Q3 | 174.93 Million EUR | 4.91% |
| 2021 Q4 | 175.04 Million EUR | 0.06% |
| 2021 FY | 673.1 Million EUR | 2.0% |
| 2020 Q4 | 161.19 Million EUR | -7.97% |
| 2020 FY | 659.9 Million EUR | -1.96% |
| 2020 Q3 | 175.15 Million EUR | 12.19% |
| 2020 Q2 | 156.13 Million EUR | -6.74% |
| 2020 Q1 | 167.41 Million EUR | -0.59% |
| 2019 Q2 | 167.79 Million EUR | 0.12% |
| 2019 Q4 | 168.4 Million EUR | -0.53% |
| 2019 FY | 673.1 Million EUR | 4.34% |
| 2019 Q1 | 167.6 Million EUR | 4.82% |
| 2019 Q3 | 169.29 Million EUR | 0.89% |
| 2018 Q4 | 159.9 Million EUR | -2.35% |
| 2018 FY | 645.1 Million EUR | 5.91% |
| 2018 Q1 | 157.69 Million EUR | 0.7% |
| 2018 Q2 | 163.51 Million EUR | 3.69% |
| 2018 Q3 | 163.75 Million EUR | 0.15% |
| 2017 Q4 | 156.6 Million EUR | 1.97% |
| 2017 Q3 | 153.57 Million EUR | 1.15% |
| 2017 Q2 | 151.83 Million EUR | 3.23% |
| 2017 Q1 | 147.08 Million EUR | 1.34% |
| 2017 FY | 609.1 Million EUR | 4.96% |
| 2016 Q1 | 141.88 Million EUR | 0.67% |
| 2016 Q2 | 147.28 Million EUR | 3.8% |
| 2016 Q3 | 146.03 Million EUR | -0.85% |
| 2016 Q4 | 145.14 Million EUR | -0.61% |
| 2016 FY | 580.34 Million EUR | 4.5% |
| 2015 Q4 | 140.93 Million EUR | 0.51% |
| 2015 FY | 555.34 Million EUR | 3.22% |
| 2015 Q3 | 140.21 Million EUR | 1.88% |
| 2015 Q2 | 137.63 Million EUR | 0.78% |
| 2015 Q1 | 136.56 Million EUR | 0.98% |
| 2014 Q2 | 134.29 Million EUR | 1.43% |
| 2014 Q1 | 132.39 Million EUR | 5.7% |
| 2014 Q4 | 135.24 Million EUR | -0.63% |
| 2014 Q3 | 136.1 Million EUR | 1.35% |
| 2014 FY | 538.03 Million EUR | 4.48% |
| 2013 Q2 | 132.96 Million EUR | 6.83% |
| 2013 Q4 | 125.25 Million EUR | -5.31% |
| 2013 FY | 514.95 Million EUR | 1.02% |
| 2013 Q1 | 124.46 Million EUR | -1.17% |
| 2013 Q3 | 132.27 Million EUR | -0.52% |
| 2012 Q2 | 128.71 Million EUR | 2.65% |
| 2012 Q3 | 129.68 Million EUR | 0.75% |
| 2012 Q4 | 125.94 Million EUR | -2.88% |
| 2012 FY | 509.73 Million EUR | 3.28% |
| 2012 Q1 | 125.4 Million EUR | -0.35% |
| 2011 Q2 | 242.89 Million EUR | 102.45% |
| 2011 Q4 | 125.84 Million EUR | 0.82% |
| 2011 Q1 | 119.97 Million EUR | -3.39% |
| 2011 FY | 493.56 Million EUR | 1.31% |
| 2011 Q3 | 124.82 Million EUR | -48.61% |
| 2010 Q4 | 124.19 Million EUR | 1.81% |
| 2010 Q3 | 121.99 Million EUR | -0.62% |
| 2010 Q2 | 122.75 Million EUR | 3.83% |
| 2010 Q1 | 118.22 Million EUR | -1.34% |
| 2010 FY | 487.16 Million EUR | 3.52% |
| 2009 Q4 | 119.83 Million EUR | 0.02% |
| 2009 FY | 470.57 Million EUR | 3.02% |
| 2009 Q1 | 112.48 Million EUR | 0.0% |
| 2009 Q3 | 119.81 Million EUR | 1.16% |
| 2009 Q2 | 118.44 Million EUR | 5.3% |
| 2008 FY | 456.79 Million EUR | 0.0% |
| 2007 FY | - EUR | 0.0% |
| 2006 FY | - EUR | -100.0% |
| 2005 FY | 370.43 Million EUR | -0.69% |
| 2004 FY | 373.02 Million EUR | -0.83% |
| 2003 FY | 376.13 Million EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 19.45 Billion EUR | 96.085% |
| Fresenius SE & Co. KGaA | 22.29 Billion EUR | 96.585% |
| LIMES Schlosskliniken AG | 37.17 Million EUR | -1948.795% |
| M1 Kliniken AG | 316.31 Million EUR | -140.77% |
| Maternus-Kliniken Aktiengesellschaft | 102.3 Million EUR | -644.432% |
| RHÖN-KLINIKUM Aktiengesellschaft | 1.73 Billion EUR | 56.097% |
| VITA 34 AG | 77.06 Million EUR | -888.294% |